Lataa…
How I treat HER2-low advanced breast cancer
INTRODUCTION: Targeting low levels of human receptor epidermal growth factor 2 (HER2) expression has reshaped the treatment paradigm for half of the patients with advanced breast cancer. HER2-low is currently defined as a HER2 immunohistochemical expression of 1+ or 2+ without amplification by in-si...
Päätekijät: | , , |
---|---|
Aineistotyyppi: | Online Artikkeli Teksti |
Kieli: | English |
Julkaistu: |
Elsevier
2023
|
Aiheet: | |
Linkit: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982266/ https://www.ncbi.nlm.nih.gov/pubmed/36669993 http://dx.doi.org/10.1016/j.breast.2023.01.005 |